1
/
of
1
Elabscience
SKU:E-CL-H1408
Human MCAM(Melanoma Cell Adhesion Molecule) CLIA Kit
Human MCAM(Melanoma Cell Adhesion Molecule) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the HUMAN MCAM (Melanoma Cell Adhesion Molecule) CLIA Kit, a cutting-edge solution designed to facilitate accurate and efficient detection of MCAM in human samples. This state-of-the-art kit is meticulously crafted to meet the highest standards of quality and reliability, ensuring precise and reproducible results.
The HUMAN MCAM CLIA Kit employs the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and specific method that enables the quantification of MCAM levels with exceptional precision. By utilizing this advanced technology, researchers and clinicians can confidently assess MCAM expression in various biological specimens, including serum, plasma, and tissue lysates.
This comprehensive kit includes all the necessary components for seamless experimentation, including pre-coated microplate wells, assay buffers, detection reagents, and a detailed protocol. The user-friendly nature of the kit allows for effortless implementation, making it suitable for both experienced laboratory professionals and novices alike.
The HUMAN MCAM CLIA Kit offers numerous advantages, such as its broad dynamic range, excellent sensitivity, and minimal sample volume requirements. These features empower researchers to accurately quantify MCAM expression across a wide range of concentrations, even in samples with limited availability.
Furthermore, this CLIA kit exhibits exceptional specificity, ensuring minimal cross-reactivity with other molecules, thereby enhancing the reliability and accuracy of MCAM detection. Its robust performance and consistent results make it an indispensable tool for studying MCAM's role in melanoma progression and metastasis.
In summary, the HUMAN MCAM CLIA Kit represents a breakthrough in MCAM detection, providing researchers and clinicians with a reliable and efficient means to explore the intricate mechanisms underlying melanoma development. With its exceptional sensitivity, specificity, and ease of use, this kit is poised to revolutionize the field of melanoma research and contribute to the advancement of diagnostic and therapeutic strategies.
The HUMAN MCAM CLIA Kit employs the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and specific method that enables the quantification of MCAM levels with exceptional precision. By utilizing this advanced technology, researchers and clinicians can confidently assess MCAM expression in various biological specimens, including serum, plasma, and tissue lysates.
This comprehensive kit includes all the necessary components for seamless experimentation, including pre-coated microplate wells, assay buffers, detection reagents, and a detailed protocol. The user-friendly nature of the kit allows for effortless implementation, making it suitable for both experienced laboratory professionals and novices alike.
The HUMAN MCAM CLIA Kit offers numerous advantages, such as its broad dynamic range, excellent sensitivity, and minimal sample volume requirements. These features empower researchers to accurately quantify MCAM expression across a wide range of concentrations, even in samples with limited availability.
Furthermore, this CLIA kit exhibits exceptional specificity, ensuring minimal cross-reactivity with other molecules, thereby enhancing the reliability and accuracy of MCAM detection. Its robust performance and consistent results make it an indispensable tool for studying MCAM's role in melanoma progression and metastasis.
In summary, the HUMAN MCAM CLIA Kit represents a breakthrough in MCAM detection, providing researchers and clinicians with a reliable and efficient means to explore the intricate mechanisms underlying melanoma development. With its exceptional sensitivity, specificity, and ease of use, this kit is poised to revolutionize the field of melanoma research and contribute to the advancement of diagnostic and therapeutic strategies.
Share
